04:49:02 EDT Fri 18 Jun 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for May 10, 2021

2021-05-10 20:12 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index lost 13.12 to 191.86, while the CSE Composite Index lost 23.30 to 800.51. The sector began the week with a multibillion-dollar merger announcement. Florida cannabis giant Trulieve Cannabis Corp. (TRUL), down $3.03 to $46.67 on 685,900 shares, is buying the largest operator in Arizona, Harvest Health & Recreation Inc. (HARV), up 49 cents to $4.84 on 6.39 million shares. The $2.1-billion (U.S.) all-share deal will create one of the largest MSOs (multistate operators) in the United States.

Harvest's shareholders will receive 0.117 of a Trulieve share for each Harvest share. Based on Friday's closing prices, this ratio values Harvest's stock at $5.81, a 33-per-cent premium. It is still barely one-third of the all-time high of $14.90 that Harvest was trading at just two years ago. The long slide reflects a troubled balance sheet. Harvest was $265-million (U.S.) in debt as of Dec. 31, with $245-million (U.S.) coming due next year, but it had just $92-million (U.S.) cash as of March 26. Founder and chief executive officer Steve White said in March that Harvest was "actively working to address our 2022 debt obligations." A takeover by Trulieve, with its large cash hoard and its ability to turn a profit -- all too rare in the cannabis industry -- is certainly one way to take care of that.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2021 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.